Henry Schein, Inc. $HSIC Shares Sold by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 67.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 484,174 shares of the company’s stock after selling 993,491 shares during the quarter. Henry Schein comprises about 2.7% of Clarkston Capital Partners LLC’s portfolio, making the stock its 12th biggest holding. Clarkston Capital Partners LLC’s holdings in Henry Schein were worth $35,684,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Bank of Nova Scotia boosted its position in Henry Schein by 1,263.1% during the first quarter. Bank of Nova Scotia now owns 116,808 shares of the company’s stock worth $8,609,000 after acquiring an additional 108,239 shares during the last quarter. State of Wyoming raised its holdings in Henry Schein by 32.9% in the 1st quarter. State of Wyoming now owns 14,555 shares of the company’s stock valued at $1,073,000 after acquiring an additional 3,605 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Henry Schein by 2.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,873,004 shares of the company’s stock worth $211,734,000 after purchasing an additional 56,687 shares in the last quarter. Parallel Advisors LLC lifted its stake in Henry Schein by 12.7% in the 1st quarter. Parallel Advisors LLC now owns 1,314 shares of the company’s stock worth $97,000 after purchasing an additional 148 shares in the last quarter. Finally, SEB Asset Management AB acquired a new position in shares of Henry Schein during the 1st quarter worth approximately $2,276,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director William K. Daniel acquired 10,000 shares of Henry Schein stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average cost of $69.19 per share, for a total transaction of $691,900.00. Following the acquisition, the director owned 20,000 shares in the company, valued at approximately $1,383,800. This represents a 100.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.89% of the company’s stock.

Wall Street Analyst Weigh In

HSIC has been the subject of several recent research reports. BMO Capital Markets started coverage on Henry Schein in a report on Wednesday, July 8th. They issued a “market perform” rating and a $85.00 price target for the company. UBS Group reissued a “neutral” rating and set a $85.00 price objective (down from $87.00) on shares of Henry Schein in a research note on Wednesday, May 6th. Mizuho cut their target price on Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Citigroup assumed coverage on Henry Schein in a report on Wednesday, April 15th. They set a “buy” rating and a $100.00 price target on the stock. Finally, Morgan Stanley reissued an “underweight” rating and issued a $64.00 price objective (up from $61.00) on shares of Henry Schein in a report on Friday, April 24th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $87.64.

Henry Schein Trading Down 0.3%

Shares of Henry Schein stock opened at $84.53 on Friday. The stock has a 50 day moving average of $80.72 and a 200 day moving average of $77.99. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.75 and a current ratio of 1.36. The firm has a market capitalization of $9.63 billion, a price-to-earnings ratio of 25.54, a PEG ratio of 1.63 and a beta of 0.81. Henry Schein, Inc. has a fifty-two week low of $61.94 and a fifty-two week high of $89.34.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 5th. The company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The company had revenue of $3.37 billion for the quarter, compared to the consensus estimate of $3.34 billion. During the same quarter in the previous year, the business earned $1.15 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, research analysts predict that Henry Schein, Inc. will post 5.32 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.